Please ensure Javascript is enabled for purposes of website accessibility

Will These Numbers from Abaxis Be Good Enough for You?

By Seth Jayson - Updated Apr 10, 2017 at 1:44PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Checking expectations

Abaxis (Nasdaq: ABAX) is expected to report Q4 earnings on April 25. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Abaxis's revenues will grow 22.8% and EPS will grow 23.8%.

The average estimate for revenue is $52.5 million. On the bottom line, the average EPS estimate is $0.26.

Revenue details
Last quarter, Abaxis tallied revenue of $49.8 million. GAAP reported sales were 32% higher than the prior-year quarter's $37.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.22. GAAP EPS of $0.22 for Q3 were 69% higher than the prior-year quarter's $0.13 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 52.4%, 170 basis points worse than the prior-year quarter. Operating margin was 15.4%, 310 basis points better than the prior-year quarter. Net margin was 10.0%, 250 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $188.5 million. The average EPS estimate is $0.79.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 163 members out of 179 rating the stock outperform, and 16 members rating it underperform. Among 41 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 37 give Abaxis a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Abaxis is outperform, with an average price target of $41.28.

Is Abaxis the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Abaxis, Inc. Stock Quote
Abaxis, Inc.
ABAX

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
327%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.